Australia's Tissue Repair climbs on second U.S. patent

Tissue Repair

05/09/2022 04:30

** Shares of biopharma company Tissue Repair  TRP.AX  rise
as much as 6.5% to A$0.330, mark their biggest intraday pct gain
since Aug. 4
    ** Granted second patent by the U.S. Patent and Trademark
Office for use of its active pharmaceutical ingredient (API)
Glucoprime for treating any skin condition  urn:newsml:reuters.com:*:nASX4FkJjt
    ** In April, TRP got its first U.S. patent on the method of
manufacturing of Glucoprime
    ** Volumes 2.2x the 30-day average of 71,641 shares
    ** As of last close, stock down 43.1% this year

 (Reporting by Himanshi Akhand in Bengaluru)
 ((Himanshi.Akhand@thomsonreuters.com;))